TONIX PHARMACEUTICALS HLDG C's ticker is TNXP and the CUSIP is 890260201. A total of 21 filers reported holding TONIX PHARMACEUTICALS HLDG C in Q1 2014. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2014 | $1,041,000 | – | 100,000 | – | 0.24% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 565,000 | $4,334,000 | 1.81% |
| Ghost Tree Capital, LLC | 350,000 | $2,685,000 | 1.10% |
| Avoro Capital Advisors LLC | 340,300 | $2,610,000 | 0.90% |
| PURA VIDA INVESTMENTS, LLC | 217,900 | $1,671,000 | 0.70% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,467,858 | $11,258,000 | 0.55% |
| Broadfin Capital, LLC | 890,748 | $6,832,000 | 0.42% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,315,551 | $10,090,000 | 0.41% |
| Lombard Odier Asset Management (USA) Corp | 348,641 | $2,674,000 | 0.26% |
| TURNER INVESTMENTS LLC | 122,000 | $936,000 | 0.19% |
| Integre Asset Management, LLC | 64,317 | $493,000 | 0.12% |